Pharmafile Logo
Pharmafocus logo
Advanced Search

Fluvoxamine effective in reducing hospitalisation in COVID-19 patients

October 29, 2021
Medical Communications

A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …

News

FDA approve Susvimo for wet age-related macular degeneration

October 29, 2021
Medical Communications

Genentech have announced that Susvimo, previously known as the port delivery system, is the fist wet age-related macular degeneration (AMD) …

News

XBiotech to launch novel therapy for stroke patients in US

October 29, 2021
Medical Communications

Clinical stage biopharmaceutical company, XBiotech, plans to test its new True Humanâ„¢ antibody therapy for reducing brain injury after stroke, …

News

Angel Pharmaceuticals receives IND approval for Phase 1/1b Inhibitor in China

October 28, 2021
Business Services

Angel Pharmaceuticals has received approval for their IND application, from the Center for Drug Evaluation (CDE) of the China National …

News
credit_-_crevis_shutterstock_340710245_720

Serial radiation therapy safe as alternative treatment for kidney cancer

October 28, 2021
Business Services

The University of Texas MD Anderson Cancer Center has reported that Serial radiation therapy as monotherapy is a safe and …

News

First long-acting HIV-treatment to be distributed in European countries

October 28, 2021
Business Services

ViiV Healthcare, the global specialist HIV company, have presented positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine), the first …

News

FDA approves Phase II clinical trial of combination treatment for COVID-19

October 28, 2021
Business Services

The FDA has approved Vitti Labs’ Investigational New Drug (IND) application to conduct Phase II Clinical Trials using a combination …

News

Plan C COVID strategy being discussed by government

October 27, 2021
Research and Development

An advisor to the Department of Health told MPs a ‘Plan C’ has been mentioned in Government discussions, should the …

News

Quell Therapeutics receives CTA approval to begin first clinical trial with a multi-modular engineered treg cell company

October 27, 2021
Research and Development

The MHRA has approved Quell Therapeutics’ first clinical trial for its lead cell therapy candidate QEL-001. This approval paves the …

News

Study finds link between COVID-19 infection and neurological complications

October 27, 2021
Research and Development

A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a …

News

FDA and EMA approve Novartis’ treatment for follicular lymphoma patients

October 27, 2021
Research and Development

The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …

News

NIHR funds COVID-19 antiviral trial

October 26, 2021
Manufacturing and Production

The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, …

News

CHMP begins rolling review of COVID oral antiviral

October 26, 2021
Manufacturing and Production

The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment …

News

Hospitals and pharmacies facing medicine shortages, says The London Economic

October 26, 2021
Manufacturing and Production

As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear …

News

MHRA licenses uterine fibroid treatment for women in Great Britain

October 26, 2021
Manufacturing and Production

The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms …

News

Infectious disease expert says children between 5-11 could be vaccinated in November

October 25, 2021
Sales and Marketing

Infectious disease expert, Dr Anthony Fauci, has said that COVID-19 vaccines for children aged 5-11 could be available by early …

News

More people self-funding routine operations as NHS waiting lists hit record levels

October 25, 2021
Sales and Marketing

New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …

News

Novartis Phase III study into canakinumab does not meet primary endpoint

October 25, 2021
Sales and Marketing

Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …

News

AstraZeneca biliary cancer drug shows improved survival rate in patients

October 25, 2021
Sales and Marketing

AstraZeneca has announced that its Imfinzi drug­­­, for the treatment of biliary tract cancer, has improved overall survival in patients …

News

Companion test for lung cancer approved by FDA

October 22, 2021
Medical Communications

The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026